EUVIMEDEUVIMED entdecken
Crossref

Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy

Yongjuan Li, Ya Dong, Danyang Shen, Yichen Guo, Yongjian Cao, Kaixin Zhang, Xinyan Li, Rongrong Zhu, Jinmeng Yi, Xiaohan Yao, Xiaowei Dang, Rui Li und 3 weitere

ACS Nano · 2025

DOI: 10.1021/acsnano.4c11014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Yongjuan Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, The First Affiliated Hospital of Zhengzhou University, The Center of Infection and Immunity, Academy of Medical Sciences, Zh…. Hauptthemen laut MEDLINE: Immunotherapy, Cancer Vaccines, Membrane Proteins, Nanoparticles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Zhengzhou University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCancer VaccinesMembrane ProteinsNanoparticlesDrug CarriersAnimalsMiceMice, Inbred C57BLOvalbuminDendritic CellsFemaleCell Line, TumorHumansNanovaccinesSTING Protein

Stichwörter der Autor:innen

STING activationa personalized nanovaccinecancer immunotherapydual-immune functional nanoplatformimmune checkpoint blockade

Substanzen

Cancer VaccinesMembrane ProteinsOvalbuminDrug CarriersNanovaccinesSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Medical Research Center, The First Affiliated Hospital of Zhengzhou University, The Center of Infection and Immunity, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
  • School of Pharmaceutical Sciences, Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou University, Zhengzhou, Henan 450001, China.

ORCID-Profile: Zhenzhong Zhang, Weijing Yang

Förderung

  • Zhengzhou University
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Dong, Y., Shen, D., Guo, Y., Cao, Y., Zhang, K., Li, X., Zhu, R., Yi, J., Yao, X., Dang, X., Li, R., Zhang, Z., Qin, Z., & Yang, W. (2025). Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c11014

Vancouver

Li Y, Dong Y, Shen D, Guo Y, Cao Y, Zhang K, et al. Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy. ACS Nano. 2025. doi:10.1021/acsnano.4c11014

BibTeX
@article{Li2025,
  author = {Li, Yongjuan and Dong, Ya and Shen, Danyang and Guo, Yichen and Cao, Yongjian and Zhang, Kaixin and Li, Xinyan and Zhu, Rongrong and Yi, Jinmeng and Yao, Xiaohan and Dang, Xiaowei and Li, Rui and Zhang, Zhenzhong and Qin, Zhihai and Yang, Weijing},
  title = {Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c11014}
}
Kostenlos starten →